- Shake hands with C-suite, board members from the largest pharmaceutical and biotechnology firms, CROs and digital health companies
- 63% of attendees in 2022 help a job title of 'Head of' or above meaning you are amongst true decision-makers
- Schedule 1-to-1 meetings with leaders in the online event community
- Establish new relationships and strengthen ties at our evening Drinks reception
Global Pharma and Biotech Summit
The world of life sciences is in a period of relentless disruption. Advances in technology are transforming research and development. Innovative treatments such as mRNA vaccines and cell therapies are reshaping healthcare as we know it. Meanwhile, companies face the challenge of bringing products to market in an unsettled regulatory environment.
The Global Pharma and Biotech Summit is the essential annual event for you to stay on top of the latest trends and innovations in life sciences. Industry leaders and experts will discuss what’s new in areas such as drug discovery, clinical trials, market access and patient engagement.
Join us in-person and online over three days as we explore new frontiers for business and for healthcare.
the technology and innovation behind innovative treatments with the power to transform healthcare.
with industry leaders responsible for the big decisions in areas such as investment, innovation and market access.
new ideas to support business transformation and maximise return on investment.
THESUPER EARLY BIRD
Access to live streamed talks and online community, Q&A and video on demand.
Limited time only
The 2022 agenda featured 50+ leading voices including:
How is global disruption affecting investment in life sciences? Where are investors putting their money? What barriers to dealmaking are causing concern?
How is artificial intelligence transforming drug discovery? What are the latest next-generation therapies? How are clinical trials evolving?
How should pharma companies approach ESG? How are key pharma job functions evolving? What are CEOs doing to drive business transformation and growth?
"The mix of high level and in-depth insights into the sector. Panel discussions and CEO one to ones were extremely insightful."
The Power of Networking
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice